Site 1022 Liver Institute Northwest is a clinical research site located in Seattle, Washington, United States 98105.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Site 1022 Liver Institute Northwest has participated in 1 clinical trials.
Therapeutic areas: NASH - Nonalcoholic Steatohepatitis.
Sponsors: Terns, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Washington · View every site in Seattle
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Site 1022 Liver Institute Northwest has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Site 1022 Liver Institute Northwest has 1 clinical trials on record. Their work covers NASH - Nonalcoholic Steatohepatitis.
Site 1022 Liver Institute Northwest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.